Title : Poster: The (alpha4)3(\/beta2)2 nAChR has a benzodiazepine-like modulatory binding site in the alphaalpha-subunit interface as revealed by studies with NS9283 - |
Author(s) : Ahring PK , Peters D , Christensen JK , Jensen ML , Harpsoe K , Balle T |
Ref : Biochemical Pharmacology , 82 :1029 , 2011 |
PubMedID: |
Ahring PK, Peters D, Christensen JK, Jensen ML, Harpsoe K, Balle T (2011)
Poster: The (alpha4)3(\/beta2)2 nAChR has a benzodiazepine-like modulatory binding site in the alphaalpha-subunit interface as revealed by studies with NS9283
Biochemical Pharmacology
82 :1029
Ahring PK, Peters D, Christensen JK, Jensen ML, Harpsoe K, Balle T (2011)
Biochemical Pharmacology
82 :1029
Array ( [id] => 145021 [paper] => Ahring_2011_Biochem.Pharmacol_82(8)_1029 [author] => Ahring PK || Peters D || Christensen JK || Jensen ML || Harpsoe K || Balle T [year] => 2011 [title] => Poster: The (alpha4)3(\/beta2)2 nAChR has a benzodiazepine-like modulatory binding site in the alphaalpha-subunit interface as revealed by studies with NS9283 [journal] => Biochemical Pharmacology [volume] => 82 [page] => 1029 [medline] => [abstract] => [kin_reference] => [mutation] => [kinetic_parameter] => [inhibitor] => [kin_value] => [substrate] => [gene_locus] => Array ( ) [family] => [interact_gene_locus] => [xenobiotic_sensitivity] => [news] => [likid_reference] => [lip_reference] => [gene_locus_frgt] => [structure] => [comment] => [chemical] => [arpigny_jaeger] => [reactivator] => [disease] => [enzyme] => [risk_factor] => [tissue] => [sub_tissue] => [activity] => [specific_activity] => [disease_by_interaction] => [abstract_text] => )